« Previous
Next »
Schizophrenia Research
Volume 78, Issue 2
, Pages 157-159
, 15 October 2005
Olanzapine versus risperidone in the treatment of post-psychotic depression in schizophrenic patients
References
- . Clinical issues related to depression in schizophrenia: an international survey of psychiatrists. Acta Psychiatr. Scand. 2002;105(3):189–195
- . Depression in schizophrenia: perspective in the era of “atypical” antipsychotic agents. Am. J. Psychiatry. 2000;157(9):1379–1389
- . Adjunctive imipramine for a broader group of post-psychotic depressions in schizophrenia. Schizophr. Res. 2000;44(3):187–192
- . Suicide and schizophrenia. J. Psychopharmacol. 2001;15(2):127–135
- . Depressive signs and symptoms in schizophrenia: a prospective blinded trial of olanzapine and haloperidol. Arch. Gen. Psychiatry. 1998;55(3):250–258
- . The course of depressive symptoms in predicting relapse in schizophrenia: a double-blind, randomized comparison of olanzapine and risperidone. Biol. Psychiatry. 1999;46365–46373
- . Antidepressants for people with both schizophrenia and depression. Cochrane Database Syst. Rev. 2002;4(2):1–40
☆ This paper was presented at the 12th Association of European Psychiatry Congress, Geneva, April 15–18th, 2004.
PII: S0920-9964(05)00234-3
doi: 10.1016/j.schres.2005.06.001
© 2005 Elsevier B.V. All rights reserved.
« Previous
Next »
Schizophrenia Research
Volume 78, Issue 2
, Pages 157-159
, 15 October 2005
